PROTAGENIC THERAPEUTIC -CW25 (PTIXW:NASDAQ)
$0.0208 0.0067 (47.5177%)
Analysed PROTAGENIC THERAPEUTIC -CW25 (PTIXW:NASDAQ) News Sources
Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114
17-03-2026
yahoo.com
Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study
13-11-2025
yahoo.com
Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance
22-08-2025
yahoo.com
Sector Update: Health Care Stocks Mixed Late Afternoon
21-08-2025
yahoo.com
Top Midday Gainers
21-08-2025
yahoo.com
Sector Update: Health Care Stocks Advance in Afternoon Trading
21-08-2025
yahoo.com
BC-Most Active Stocks
21-08-2025
yahoo.com
Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders
21-08-2025
yahoo.com
Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates
30-07-2025
yahoo.com
Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity
21-05-2025
yahoo.com
What is the current price of PROTAGENIC THERAPEUTIC -CW25 (PTIXW:NASDAQ)?
The current price of PROTAGENIC THERAPEUTIC -CW25 (PTIXW:NASDAQ) is $0.0208.
PROTAGENIC THERAPEUTIC -CW25 (PTIXW:NASDAQ) absolute price change since previous trading day?
The absolute price change of PROTAGENIC THERAPEUTIC -CW25 (PTIXW:NASDAQ) since the previous trading day is $0.0067.
PROTAGENIC THERAPEUTIC -CW25 (PTIXW:NASDAQ) percentage price change since previous trading day?
The percentage price change of PROTAGENIC THERAPEUTIC -CW25 (PTIXW:NASDAQ) since the previous trading day is 47.5177%.
What is the most recent average sentiment score for PROTAGENIC THERAPEUTIC -CW25 (PTIXW:NASDAQ)?
The most recent average sentiment score for PROTAGENIC THERAPEUTIC -CW25 (PTIXW:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for PROTAGENIC THERAPEUTIC -CW25 (PTIXW:NASDAQ)?
The most recent sentiment for PROTAGENIC THERAPEUTIC -CW25 (PTIXW:NASDAQ) is .
SEC-8K** Filing Available For PROTAGENIC THERAPEUTIC -CW25 (PTIXW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.